Morita T, Maniwa T, Satoh K, Taira N
J Pharmacol Exp Ther. 1985 Sep;234(3):728-34.
Whether pressor responses mediated by alpha-2 adrenoceptors are more susceptible to calcium antagonists than those mediated by alpha-1 adrenoceptors was investigated in anesthetized, spinal dogs. All drugs were administered i.v. Methoxamine (3-100 mu/kg) or xylazine (3-300 micrograms/kg) produced a sustained increase in mean arterial pressure but almost no effect on heart rate. Both the initial and the sustained phase of the pressor response to methoxamine were selectively antagonized by prazosin, whereas those to xylazine were selectively antagonized by yohimbine. These results indicate that the peripheral arterial bed of the dog comprises alpha-1 and alpha-2 adrenoceptors and that both the initial and sustained phases of the pressor response to methoxamine are predominantly mediated by alpha-1 adrenoceptors, whereas those to xylazine are mediated by alpha-2 adrenoceptors. The calcium antagonists, i.e., nifedipine (0.3-3 micrograms/kg), diltiazem (10-100 micrograms/kg) and KB-944 (10-100 micrograms/kg), administered during the sustained phase of the pressor responses to equieffective doses of methoxamine (100 micrograms/kg) and xylazine (1000 micrograms/kg), lowered mean arterial pressure. The three calcium antagonists in these doses also lowered the baseline mean arterial pressure but to a lesser extent than the elevated one. These results altogether indicate that the calcium antagonists were more effective in lowering mean arterial pressure elevated by either an alpha-1 or alpha-2 adrenoceptor agonist than the base-line mean arterial pressure and that the sustained phase of the pressor response mediated by alpha-1 adrenoceptors would involve Ca++ influx as much as or more than those mediated by alpha-2 adrenoceptors.
在麻醉的脊髓犬中研究了由α-2肾上腺素能受体介导的升压反应是否比由α-1肾上腺素能受体介导的升压反应对钙拮抗剂更敏感。所有药物均静脉注射。甲氧明(3 - 100μg/kg)或赛拉嗪(3 - 300μg/kg)使平均动脉压持续升高,但对心率几乎无影响。对甲氧明升压反应的初始阶段和持续阶段均被哌唑嗪选择性拮抗,而对赛拉嗪的升压反应则被育亨宾选择性拮抗。这些结果表明,犬的外周动脉床包含α-1和α-2肾上腺素能受体,对甲氧明升压反应的初始阶段和持续阶段主要由α-1肾上腺素能受体介导,而对赛拉嗪的升压反应由α-2肾上腺素能受体介导。在对等效剂量的甲氧明(100μg/kg)和赛拉嗪(1000μg/kg)升压反应的持续阶段给予钙拮抗剂,即硝苯地平(0.3 - 3μg/kg)、地尔硫䓬(10 - 100μg/kg)和KB - 944(10 - 100μg/kg),可降低平均动脉压。这三种钙拮抗剂在这些剂量下也降低了基础平均动脉压,但程度小于升高后的平均动脉压。这些结果总体表明,钙拮抗剂在降低由α-1或α-2肾上腺素能受体激动剂升高的平均动脉压方面比基础平均动脉压更有效,并且由α-1肾上腺素能受体介导的升压反应的持续阶段涉及的Ca++内流与由α-2肾上腺素能受体介导的升压反应相同或更多。